Krebs von den Lungen-6 glycoprotein circulating levels are not useful as prognostic marker in COVID-19 pneumonia: A large prospective cohort study

Coronavirus disease 2019 (COVID-19) has rapidly expanded worldwide. Currently, there are no biomarkers to predict respiratory worsening in patients with mild to moderate COVID-19 pneumonia. Small studies explored the use of Krebs von de Lungen-6 circulating serum levels (sKL-6) as a prognostic bioma...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Ivan Castellví, Diego Castillo, Hèctor Corominas, Anaís Mariscal, Sandra Orozco, Natividad Benito, Virginia Pomar, Andrés Baucells, Isabel Mur, David de la Rosa-Carrillo, David Lobo, Ana Milena Millan, Nerea Hernández de Sosa, David Filella, Laia Matas, Laura Martínez-Martínez, Cándido Juarez, Jordi Casademont, Pere Domingo
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2022-08-01
Serie:	Frontiers in Medicine
Soggetti:	COVID-19 Krebs von den Lungen-6 (KL-6) pneumonia biomarker predictor
Accesso online:	https://www.frontiersin.org/articles/10.3389/fmed.2022.973918/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!